Brett A. Grimaud serves as Executive at Theravance Biopharma, Inc., where they oversee executive responsibilities. Since joining the company, Brett A. Grimaud has executed 12 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 20, 2026 involved selling 20,833 shares valued at $409.6K.
Brett A. Grimaud currently holds 334,449 shares of Theravance Biopharma, Inc. (TBPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Brett A. Grimaud has been a net neutral trader of TBPH stock. They have purchased $0 and sold $0 worth of shares.
Brett A. Grimaud's most recent insider trade was on Feb 20, 2026, when they sold 20,833 shares at $19.66 per share.
Get notified when new Form 4 filings are submitted
| $17.90 |
| Discretionary |
| Aug 20, 2025 | TBPH | $130.7K | Payment | 9,762 | $13.39 | Discretionary |
| Aug 20, 2024 | TBPH | $76.2K | Payment | 9,268 | $8.22 | Discretionary |
| May 20, 2024 | TBPH | $84.3K | Payment | 9,268 | $9.10 | Discretionary |
| Apr 2, 2024 | TBPH | $0 | Award | 100,000 | $N/A | Discretionary |
| Feb 20, 2024 | TBPH | $156.9K | Payment | 17,595 | $8.92 | Discretionary |
| Nov 20, 2023 | TBPH | $76.4K | Payment | 7,363 | $10.37 | Discretionary |
| Aug 20, 2023 | TBPH | $86.4K | Payment | 8,912 | $9.70 | Discretionary |
| May 20, 2023 | TBPH | $128.6K | Payment | 11,469 | $11.21 | Discretionary |
| Mar 1, 2023 | TBPH | $0 | Award | 75,000 | $N/A | Discretionary |
| Feb 20, 2023 | TBPH | $106.5K | Payment | 10,198 | $10.44 | Discretionary |